Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)
CUSIP: 59935V107
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 124,817,707
- Total 13F shares
- 30,178,631
- Share change
- -916,662
- Total reported value
- $39,890,373
- Put/Call ratio
- 0%
- Price per share
- $1.32
- Number of holders
- 39
- Value change
- -$1,767,212
- Number of buys
- 11
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 59935V107?
CUSIP 59935V107 identifies MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 59935V107:
Top shareholders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
3/4/5
13F
|
10%+ Owner · Company |
2.6%
from 13F
|
3,256,102
|
$28,360,648 | — | 22 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4%
|
4,971,344
|
$8,898,706 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.3%
|
2,855,612
|
$5,111,545 | — | 31 Mar 2024 | |
| Alta Fundamental Advisers LLC |
13F
|
Company |
1.9%
|
2,371,289
|
$4,244,607 | — | 31 Mar 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
1.8%
|
2,300,207
|
$4,117,371 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
2,272,404
|
$4,067,603 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.6%
|
2,000,000
|
$3,580,000 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.4%
|
1,750,000
|
$3,132,500 | — | 31 Mar 2024 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1.2%
|
1,462,296
|
$2,617,510 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,353,067
|
$2,421,990 | — | 31 Mar 2024 | |
| Bleichroeder LP |
13F
|
Company |
1.1%
|
1,326,085
|
$2,373,692 | — | 31 Mar 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.97%
|
1,212,882
|
$2,171,059 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.66%
|
819,828
|
$1,467,492 | — | 31 Mar 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.52%
|
650,000
|
$1,163,500 | — | 31 Mar 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
0.49%
|
606,145
|
$1,085,000 | — | 31 Mar 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.4%
|
500,000
|
$895,000 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.37%
|
466,019
|
$834,174 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.22%
|
273,100
|
$786,528 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.25%
|
309,007
|
$553,123 | — | 31 Mar 2024 | |
| Paul F. Truex |
3/4/5
|
Director |
—
mixed-class rows
|
81,897
mixed-class rows
|
$383,548 | — | 31 May 2022 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.16%
|
202,460
|
$362,403 | — | 31 Mar 2024 | |
| Ancora Advisors LLC |
13F
|
Company |
0.05%
|
60,000
|
$107,400 | — | 31 Mar 2024 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.04%
|
51,833
|
$92,781 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
39,450
|
$70,615 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
30,779
|
$55,094 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
28,316
|
$50,686 | — | 31 Mar 2024 | |
| Clear Creek Financial Management, LLC |
13F
|
Company |
0.02%
|
25,000
|
$44,750 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
18,923
|
$33,872 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
17,576
|
$31,461 | — | 31 Mar 2024 | |
| Cetera Investment Advisers |
13F
|
Company |
0.01%
|
17,427
|
$31,194 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
16,900
|
$30,251 | — | 31 Mar 2024 | |
| Beta Wealth Group, Inc. |
13F
|
Company |
0.01%
|
14,127
|
$25,287 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
13,403
|
$23,991 | — | 31 Mar 2024 | |
| Creative Planning |
13F
|
Company |
0.01%
|
13,080
|
$23,413 | — | 31 Mar 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
10,500
|
$18,795 | — | 31 Mar 2024 | |
| Valeo Financial Advisors, LLC |
13F
|
Company |
0.01%
|
10,000
|
$16,600 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.01%
|
7,100
|
$11,923 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
6,000
|
$10,740 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,618
|
$4,686 | — | 31 Mar 2024 | |
| ICA Group Wealth Management, LLC |
13F
|
Company |
0%
|
200
|
$358 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
194
|
$347 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
100
|
$179 | — | 31 Mar 2024 | |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP |
13F
|
Company |
0%
|
100
|
$179 | — | 31 Mar 2024 | |
| Richard C. Pasternak |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
— | — | 07 Jun 2023 |
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) as of Q2 2024
As of 30 Jun 2024,
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,178,631 shares.
The largest 10 holders included
BlackRock Inc., RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, Alta Fundamental Advisers LLC, Lion Point Capital, LP, CITADEL ADVISORS LLC, ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, GOLDMAN SACHS GROUP INC, and Bleichroeder LP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
40
Q2 2024 holders
39
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.